This was evidenced by more stable body weight and markedly lower levels of CRS-associated biomarkers, including mouse IL-6 and serum amyloid A-3 (SAA-3), in the serum (Figures S7B and S7C). This evidence concerns the gene SAA3P and congenital rubella syndrome.